Condition: Common Cold · Sponsor: Tasly Pharmaceutical Group Co., Ltd
To further evaluate the efficacy and safety of Antiwei granule in the treatment of common cold (wind-cold syndrome)
This description comes directly from the study's public registry record.
Rui Liu · 022-86343726 · liurui2@tasly.com
Always discuss trial participation with your own doctor first.
| Beijing Hospital of Traditional Chinese Medicine, Capital Medical University | Beijing, China | Recruiting |
| changsha Hospital Affiliated to Hunan University | Changsha, China | Recruiting |
| Chengdu Pidu District Hospital of TCM | Chengdu, China | Recruiting |
| Heilongiang Provincial Traditional Chinese Medicine Hospital | Haerbin, China | Recruiting |
| The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine | Haerbin, China | Recruiting |
| Huizhou Third People's Hospital | Huizhou, China | Recruiting |
| Kaifeng Hospital of Traditional Chinese Medicine | Kaifeng, China | Recruiting |
| Luoyang Third People's Hospital | Luoyang, China | Recruiting |
| The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University | Luzhou, China | Recruiting |
| The Affiliated Hospital of Jiangxi Uniwersity of TCM | Nanchang, China | Recruiting |
| Panjin Liaoyou Baoshihua Hospital | Panjin, China | Recruiting |
| Quzhou People's Hospital | Quzhou, China | Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06697886